Completed PHASE4 INTERVENTIONAL 1-arm NCT01342445

Effects of LDX on Functioning of College Students With ADHD

Effects of Vyvanse on the Behavioral, Academic, and Psychosocial Functioning of College Students With ADHD

Sponsor: Lehigh University

Conditions Attention-deficit/Hyperactivity Disorder

Interventions Placebo lisdexamfetamine dimesylate

Updated 7 times since 2017 Last updated: Apr 22, 2025 Started: Sep 30, 2009 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01342445, this PHASE4 trial focuses on Attention-deficit/Hyperactivity Disorder and remains completed. Sponsored by Lehigh University, it has been updated 7 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

May 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — May 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Dec 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lehigh University
University of Rhode Island

Data source: University of Rhode Island

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethlehem, United States
• Kingston, United States